ANIK - Anika Therapeutics, Inc.

Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies.

As of Jun 30, 2026: spot at $14.50, ATM IV 87.0%, max pain $15.00, net GEX $1.3K.

Sector
Healthcare
Industry
Medical - Devices
Market Cap
$200.9M
Beta
0.23
52-Week Range
7.87-16.24
CEO
Stephen D. Griffin
Employees
288
IPO Date
May 3, 1993
Exchange
NASDAQ

What ANIK Looks Like to Options Traders Today

IV rank of 17.5% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($1.3K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (-0.455) prices puts richer than calls, the typical equity downside-protection skew.

What This Page Covers

The ANIK overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.

Frequently asked ANIK overview questions

What is ANIK?
ANIK is the ticker symbol for Anika Therapeutics, Inc., a listed security. Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Listed on NASDAQ. ANIK is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
What does the ANIK options snapshot look like today?
As of Jun 30, 2026, the ANIK options snapshot shows spot at $14.50, ATM IV 87.0%, IV rank 17.5%, max pain $15.00, net GEX $1.3K, expected move 24.94%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
What are ANIK's key statistics?
Anika Therapeutics, Inc. (ANIK) carries a market capitalization of $200.9M, beta of 0.23 relative to the broader market, 52-week range of 7.87-16.24. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
What sector or industry does ANIK belong to?
Anika Therapeutics, Inc. operates in the Healthcare sector, in the Medical - Devices industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ANIK's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
How current is the ANIK data on this page?
The options snapshot above is dated Jun 30, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).